Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2009 2
2010 3
2011 2
2012 5
2013 9
2014 13
2015 5
2016 13
2017 14
2018 17
2019 15
2020 13
2021 14
2022 16
2023 21
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Fu X, Liu J, Zhao Y, Escaned J, Wang Y, Fearon WF, Dou K, Kirtane AJ, Wu Y, Serruys PW, Yang W, Wijns W, Guan C, Leon MB, Qiao S, Stone GW; FAVOR III China study group. Xu B, et al. Among authors: pan h. Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 4. Lancet. 2021. PMID: 34742368 Clinical Trial.
Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome: The H-REPLACE Randomized Equivalence and Noninferiority Trial.
Zhou S, Xiao Y, Zhou C, Zheng Z, Jiang W, Shen Q, Zhu C, Pan H, Liu C, Zeng G, Ge L, Zhang Y, Ouyang Z, Fu G, Pan G, Chen F, Huang L, Liu Q; H-REPLACE Investigators. Zhou S, et al. Among authors: pan h. JAMA Netw Open. 2023 Feb 1;6(2):e2255709. doi: 10.1001/jamanetworkopen.2022.55709. JAMA Netw Open. 2023. PMID: 36763358 Free PMC article. Clinical Trial.
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions.
Song L, Xu B, Tu S, Guan C, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Zhang R, Liu J, Zhao Y, Wang Y, Dou K, Kirtane AJ, Wu Y, Wijns W, Yang W, Leon MB, Qiao S, Stone GW; FAVOR III China Study Group. Song L, et al. Among authors: pan h. J Am Coll Cardiol. 2022 Nov 29;80(22):2089-2101. doi: 10.1016/j.jacc.2022.09.007. Epub 2022 Sep 19. J Am Coll Cardiol. 2022. PMID: 36424680 Free article. Clinical Trial.
Outcomes of Functionally Complete vs Incomplete Revascularization: Insights From the FAVOR III China Trial.
Zhang R, Wang HY, Dou K, Yin D, Zhu C, Feng L, Zhou Y, Pu J, Zhang Q, Pan H, Mi J, Ye F, Cheng X, Guo N, Guan C, Song L, Qiao S, Tu S, Xu B, Stone GW; FAVOR III China Study Group. Zhang R, et al. Among authors: pan h. JACC Cardiovasc Interv. 2022 Dec 26;15(24):2490-2502. doi: 10.1016/j.jcin.2022.10.014. JACC Cardiovasc Interv. 2022. PMID: 36543443 Free article.
151 results